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HIV infection among people who inject drugs (IDU) remains a major global public health challenge. However,
among IDU, access to essential HIV-related services remains unacceptably low, especially in settings where stigma,
discrimination, and criminalization exist. These ongoing problems account for a significant amount of preventable
morbidity and mortality within this population, and indicate the need for novel approaches to HIV program delivery
for IDU. Task shifting is a concept that has been applied successfully in African settings as a way to address health
worker shortages. However, to date, this concept has not been applied as a means of addressing the social and
structural barriers to HIV prevention and treatment experienced by IDU. Given the growing evidence demonstrating
the effectiveness of IDU-run programs in increasing access to healthcare, the time has come to extend the notion
of task shifting and apply it in settings where stigma, discrimination, and criminalization continue to pose
significant barriers to HIV program access for IDU. By involving IDU more directly in the delivery of HIV programs,
task shifting may serve to foster a new era in the response to HIV/AIDS among IDU.
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(IDU) remains a major public health challenge globally.
This epidemic persists despite the fact that a range of ef-
fective preventive interventions and treatments exist [1]. A
review by the Reference Group to the UN on HIV and
Injecting Drug Use concluded that access to HIV preven-
tion, treatment and care among IDU globally was extremely
low and that urgent action was needed to rectify this situ-
ation [2]. Various factors contributing to low access to HIV
prevention and treatment among IDU have been identified,
including the unavailability of programs, as well as an
overreliance on drug law enforcement, incarceration, and
mandatory drug detention programs as primary responses
to the harms of injection drug use [3–6].
A growing body of literature highlights a range of down-
stream social and behavioural impacts of the global em-
phasis on drug law enforcement. For example, fear of* Correspondence: uhri-tk@cfenet.ubc.ca
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reproduction in any medium, provided the orconfrontations with police perpetuates unwillingness
among IDU to access essential HIV-related services [7,8].
The emphasis on punishment of IDU for their behaviours
also fuels negative public opinion of this population, includ-
ing among healthcare workers, which makes ensuring ac-
cess to prevention and treatment of HIV challenging if not
impossible [8,9]. For example, throughout the Asia-Pacific
region, many IDU encounter delays in the provision of
healthcare services, refusal of treatment by healthcare
workers, as well as breaches of confidentiality, including
sharing of information between healthcare workers and po-
lice [10,11]. In some settings, individuals are registered as
drug users within national or regional databases upon seek-
ing care or treatment [8]. Negative physician attitudes to-
wards HIV-positive IDU have also led to suboptimal ART
treatment and care for this subpopulation due to concerns
over non-adherence and antiretroviral resistance [11–13].
Pervasive stigma and the associated self-imposed isolation
that often results can also render individuals reluctant to
access services due to fears that family, community mem-
bers, and employers may shun them for their drug using
behaviours [14–16]. Collectively, these barriers to HIVtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Ti and Kerr Harm Reduction Journal 2013, 10:20 Page 2 of 3
http://www.harmreductionjournal.com/content/10/1/20prevention and treatment highlight the urgent need for
novel methods of healthcare delivery for this population.
One concept that has been applied to improve the deliv-
ery of HIV services in African settings is that of task
shifting. Defined as the systematic delegation of tasks from
specialized cadres to cadres with less training such as
nurses or lay workers, task shifting has been used as an ef-
fective strategy to address the current healthcare worker
shortage in many African countries [17–20]. A body of lit-
erature supports the use of task shifting as a successful ap-
proach in delivering healthcare services including HIV
testing, counseling, and ART treatment by lay workers
[21–24]. In addition to the success of this model among
heterosexual populations within resource limited settings, a
systematic review has revealed that task shifting can also be
applied effectively to more marginalized populations, in-
cluding men who have sex with men [25]. In addition to
the role of task shifting as a means to improve coverage of
HIV services, this concept has also been applied to alleviate
the economic burden imposed on many developing coun-
tries [18]. Due to recent financial cutbacks made by the
Global Fund to Fight AIDS, Tuberculosis and Malaria, the
organization is now considerably more limited in its ability
to respond to the global HIV pandemic [26,27]. In a time
when resources are scarce, task shifting may help to relieve
this situation and attempt to avert the HIV/AIDS crisis.
In light of the ongoing problems in ensuring access to es-
sential HIV prevention and treatment services for IDU,
there may be an opportunity to reconceptualize task
shifting as a way of overcoming social and structural bar-
riers to HIV-related services. A large body of evidence
indicates that peer-run initiatives can extend the reach and
effectiveness of conventional public health programs
by reaching high-risk IDU [28–30]. Accordingly, the WHO,
UNODC, UNAIDS Technical Guide recommend
community-based outreach methods as an essential ap-
proach for service delivery [1]. However, the involvement of
IDU in providing HIV services need not be limited to those
efforts that aim to extend the reach of existing programs
and may have value in other areas. Shifting HIV services
from professional healthcare workers to peers may also
serve to address the existing stigma that IDU experience
within healthcare settings, thereby improving access to
these services, especially in the Asia-Pacific region where
the annual prevalence of HIV testing among IDU is as low
as 20% [31]. By creating peer-involved HIV testing clinics
and pairing physicians with peers, IDU may be more likely
to use these services without fear of being discriminated by
healthcare workers or fear of being registered as drug users
within official registries. Indeed, past research has shown
that drug-user led interventions are more acceptable to
IDU than conventional public health programs,[32–34] and
that this is due in part to perceived acceptance of their drug
use behaviors by their peers [28,29]. In this sense, theremay also be potential for peer-delivered HIV services that
do not involve healthcare professionals, as many IDU may
prefer to have their peers deliver these services to avoid fre-
quent interactions with healthcare workers.
Additionally, task shifting may avert some problems
caused by police in countries with a heavy reliance on
law enforcement. By shifting delivery of care from
healthcare professionals to peers, or by incorporating
peer workers into professionally-led services, a reduction
in stigma and discrimination in these settings may be
achieved [32]. Likewise, this type of shift in service deliv-
ery may address some concerns among IDU about infor-
mation sharing between public health systems and
enforcement officials.
While there is potential for task shifting to reduce
stigma and discrimination in these settings and thus pro-
vide greater coverage of HIV prevention and treatment
services, it is important to recognize the political bar-
riers that may restrict the wide implementation of these
programs; particularly, the lack of governmental and
public support for harm reduction programs. Therefore,
in order for task shifting to be successfully and sustain-
ably implemented within these settings, there is still a
need to shift public and policy thinking towards harm
reduction practices through the collective involvement
of the community, researchers, service providers, advo-
cates, and policy makers.
HIV/AIDS among IDU has taken a massive toll in terms
of human suffering and economic impacts in countries
throughout the world. High rates of preventable HIV infec-
tion, HIV-related morbidity and mortality among IDU, as
well as increasing expenditures on HIV-related care and
treatment services are major consequences of suboptimal
HIV prevention and treatment. There is now an obvious
need for innovation in the delivery of programs and ser-
vices for IDU. Given the evidence indicating positive bene-
fits of peer-led interventions for IDU, as well as the success
of task shifting in settings with human health resource
shortages, shifting the delivery of conventional HIV/AIDS
programs and services to IDU themselves may serve to ad-
dress the severe stigmatization and discrimination that
characterizes the existing healthcare context in many set-
tings hard hit by IDU-driven HIV epidemics. In turn, this
novel approach to task shifting may foster a new era in the
response to HIV among IDU.
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